TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Lundbeck Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2020/12 |
| Turnover |
2,143
|
2,280
|
2,576 |
| Earnings before taxes |
291
|
291
|
-587 |
| Total assets |
2,243
|
1,694
|
1,892 |
| Current assets |
2,222
|
1,620
|
1,813 |
| Current liabilities |
1,903
|
1,382
|
2,107 |
| Equity capital |
340
|
624
|
-215 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Solvency |
15.2%
|
36.8%
|
-11.4% |
| Turnover per employee |
143
|
152
|
172 |
| Profit as a percentage of turnover |
13.6%
|
12.8%
|
-22.8% |
| Return on assets (ROA) | |||
| Current ratio |
116.8%
|
117.2%
|
86.0% |
| Return on equity (ROE) |
85.6%
|
46.6%
|
273.0% |
| Change turnover |
-132
|
-297
|
252 |
| Change turnover % |
-6%
|
-12%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.